Efficacy and safety of prolonged‐release tacrolimus in stable pediatric allograft recipients converted from immediate‐release tacrolimus – a Phase 2, open‐label, single‐arm, one‐way crossover study

There are limited clinical data regarding prolonged‐release tacrolimus (PR‐T) use in pediatric transplant recipients. This Phase 2 study assessed the efficacy and safety of PR‐T in stable pediatric kidney, liver, and heart transplant recipients (aged ≥5 to ≤16 years) over 1 year following conversion...

Descripción completa

Detalles Bibliográficos
Autores principales: Rubik, Jacek, Debray, Dominique, Kelly, Deirdre, Iserin, Franck, Webb, Nicholas J. A., Czubkowski, Piotr, Vondrak, Karel, Sellier‐Leclerc, Anne‐Laure, Rivet, Christine, Riva, Silvia, Tönshoff, Burkhard, D'Antiga, Lorenzo, Marks, Stephen D., Reding, Raymond, Kazeem, Gbenga, Undre, Nasrullah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6852421/
https://www.ncbi.nlm.nih.gov/pubmed/31325368
http://dx.doi.org/10.1111/tri.13479

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6852421/
https://www.ncbi.nlm.nih.gov/pubmed/31325368
http://dx.doi.org/10.1111/tri.13479

Ejemplares similares